Potency and Selectivity of BTK Inhibitors in Clinical Development for B-Cell Malignancies.

Autor:	Kaptein, Allard, de Bruin, Gerjan, Hoek, Maaike Emmelot-van, van de Kar, Bas, de Jong, Anouk, Gulrajani, Michael, Demont, Dennis, Covey, Todd, Mittag, Diana, Barf, Tjeerd
Zdroj:	Clinical Lymphoma, Myeloma & Leukemia; 2019 Supplement 1, Vol. 19, pS316-S317, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect